Clinical trial
Evaluation of ZD1839 (NSC #715055) for Advanced Transitional Cell Carcinoma of the Urothelium, Phase II
NCT00014144 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of ZD1839 (NSC #715055) for Advanced Transitional Cell Carcinoma of the Urothelium, Phase II
- Lead sponsor
- SWOG Cancer Research Network
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2001
- Completion date
- December 31, 2007
- Enrollment
- 31 (actual)
- Sites
- 95
Conditions
As the registry lists them; a condition with its own page is linked.
bladder cancer, transitional cell cancer of the renal pelvis and ureter, urethral cancer